AGÕæÈ˹ٷ½

STOCK TITAN

Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)

Xebra Brands (OTCQB:XBRAF) has announced three significant developments: First, the company has terminated its non-binding Letter of Intent to acquire BSK Holdings Inc., originally announced on April 24th, 2025, after determining it wasn't in the company's best interest following due diligence.

Despite the terminated acquisition, Xebra will maintain its partnership with BSK to launch its ELEMENTS� CBD product line in the United States. Additionally, the company has disclosed a delay in filing its annual financial statements for the year ended February 28, 2025, resulting in a voluntary Management Cease Trade Order (MCTO).

Lastly, Xebra has secured a C$110,000 loan from an existing shareholder at 10% annual interest, maturing in one year, to support working capital needs and complete the delayed annual audit.

Xebra Brands (OTCQB:XBRAF) ha annunciato tre sviluppi importanti: in primo luogo, la società ha terminato la sua Lettera di Intenti non vincolante per acquisire BSK Holdings Inc., originariamente annunciata il 24 aprile 2025, dopo aver determinato che non fosse nell'interesse dell'azienda a seguito della due diligence.

Nonostante la cessazione dell'acquisizione, Xebra manterrà la sua partnership con BSK per il lancio della linea di prodotti ELEMENTS� CBD negli Stati Uniti. Inoltre, la società ha comunicato un ritardo nella presentazione dei bilanci annuali per l'anno terminato il 28 febbraio 2025, che ha comportato un Ordine Volontario di Sospensione dal Commercio da parte della direzione (MCTO).

Infine, Xebra ha ottenuto un prestito di 110.000 C$ da un azionista esistente con un interesse annuo del 10%, con scadenza a un anno, per sostenere le esigenze di capitale circolante e completare la revisione annuale ritardata.

Xebra Brands (OTCQB:XBRAF) ha anunciado tres desarrollos significativos: primero, la compañía ha cancelado su Carta de Intención no vinculante para adquirir BSK Holdings Inc., originalmente anunciada el 24 de abril de 2025, tras determinar que no era lo mejor para la empresa después de la debida diligencia.

A pesar de la cancelación de la adquisición, Xebra mantendrá su asociación con BSK para lanzar su línea de productos ELEMENTS� CBD en Estados Unidos. Además, la compañía ha informado un retraso en la presentación de sus estados financieros anuales para el año terminado el 28 de febrero de 2025, lo que resultó en una Orden Voluntaria de Suspensión de Comercio por parte de la gerencia (MCTO).

Por último, Xebra ha asegurado un préstamo de 110,000 C$ de un accionista existente con un interés anual del 10%, con vencimiento a un año, para apoyar las necesidades de capital de trabajo y completar la auditoría anual retrasada.

Xebra Brands (OTCQB:XBRAF)ëŠ� ì„� 가지 중요í•� 소ì‹ì� 발표했습니다: 첫째, 회사ëŠ� 2025ë…� 4ì›� 24ì¼ì— ì²˜ìŒ ë°œí‘œí•� BSK Holdings Inc. ì¸ìˆ˜ì—� 대í•� 구ì†ë � 없는 ì˜í–¥ì„œë¥¼ 종료했습니다. ì´ëŠ” 실사ë¥� ê±°ì³ íšŒì‚¬ì� ì´ìµì—� 부합하지 않는다고 íŒë‹¨í–ˆê¸° 때문입니ë‹�.

ì¸ìˆ˜ 종료ì—ë„ ë¶ˆêµ¬í•˜ê³ , XebraëŠ� BSK와ì� 파트너십ì� 유지하여 미국ì—서 ELEMENTSâ„� CBD 제품 ë¼ì¸ì� 출시í•� 예정입니ë‹�. ë˜í•œ, 회사ëŠ� 2025ë…� 2ì›� 28ì� 종료 ì—°ë„ì—� 대í•� ì—°ê°„ 재무제표 제출ì� 지연ë˜ì–� ìžë°œì ì¸ ê²½ì˜ìž� 거래정지명령(MCTO)ì� 받았다고 ë°í˜”습니ë‹�.

마지막으ë¡�, XebraëŠ� 기존 주주로부í„� ì—� 10% ì´ìžìœ¨ì˜ 11ë§� ìºë‚˜ë‹¤ë‹¬ëŸ�(C$) 대ì¶�ì� 확보했으ë©�, 만기ëŠ� 1년으ë¡� ìš´ì˜ìžê¸ˆ 필요와 ì§€ì—°ëœ ì—°ê°„ ê°ì‚¬ 완료ë¥� ì§€ì›í•˜ê¸� 위한 것입니다.

Xebra Brands (OTCQB:XBRAF) a annoncé trois développements importants : premièrement, la société a mis fin à sa lettre d'intention non contraignante visant à acquérir BSK Holdings Inc., initialement annoncée le 24 avril 2025, après avoir déterminé que cela n'était pas dans l'intérêt de l'entreprise suite à une diligence raisonnable.

Malgré l'annulation de l'acquisition, Xebra conservera son partenariat avec BSK pour lancer sa gamme de produits ELEMENTS� CBD aux États-Unis. De plus, la société a révélé un retard dans le dépôt de ses états financiers annuels pour l'exercice clos le 28 février 2025, ce qui a entraîné une ordonnance volontaire de suspension de négociation par la direction (MCTO).

Enfin, Xebra a obtenu un prêt de 110 000 C$ auprès d'un actionnaire existant avec un taux d'intérêt annuel de 10%, arrivant à échéance dans un an, afin de soutenir les besoins en fonds de roulement et de compléter l'audit annuel retardé.

Xebra Brands (OTCQB:XBRAF) hat drei bedeutende Entwicklungen bekanntgegeben: Erstens hat das Unternehmen den unverbindlichen Letter of Intent zum Erwerb von BSK Holdings Inc., ursprünglich am 24. April 2025 angekündigt, beendet, nachdem festgestellt wurde, dass dies nicht im besten Interesse des Unternehmens nach der Due Diligence ist.

Trotz des abgebrochenen Erwerbs wird Xebra die Partnerschaft mit BSK beibehalten, um die ELEMENTS� CBD-Produktlinie in den Vereinigten Staaten einzuführen. Zudem hat das Unternehmen eine Verzögerung bei der Einreichung seiner Jahresabschlüsse für das am 28. Februar 2025 endende Geschäftsjahr bekanntgegeben, was zu einer freiwilligen Management-Handelsaussetzung (MCTO) führte.

Schließlich hat Xebra ein Darlehen in Höhe von 110.000 C$ von einem bestehenden Aktionär mit 10 % Jahreszins aufgenommen, das in einem Jahr fällig ist, um den Betriebskapitalbedarf zu decken und die verzögerte Jahresprüfung abzuschließen.

Positive
  • None.
Negative
  • Termination of BSK Holdings acquisition after due diligence
  • Delayed annual financial filings resulting in Management Cease Trade Order
  • Company facing liquidity constraints requiring emergency loan
  • 10% interest rate on new loan indicates challenging financing conditions

Continued Partnership to Bring ELEMENTS� CBD Product Line to U.S. Market

VANCOUVER, BC / / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) a leading innovator in the North American cannabis market, announces the termination of its non‑binding Letter of Intent ("LOI") to acquire 100% of the outstanding shares of BSK Holdings Inc. ("BSK"), announced on April 24th, 2025.

The contemplated transaction was subject to various conditions including satisfactory due diligence and regulatory approvals, and following a thorough review and ongoing discussions, Xebra determined that it is in the Company's best interest to not proceed with the proposed acquisition. "We sincerely appreciate the professionalism and collaboration shown by the BSK team throughout this process," said Rodrigo Gallardo, Interim CEO of Xebra Brands. "While we will not be moving forward with a corporate transaction, we maintain a high regard for BSK's expertise and vision."

Despite the decision to terminate the LOI, Xebra is pleased to confirm that its partnership with BSK remains active and productive. As previously announced on May 14, 2025, Xebra and BSK executed a manufacturing and distribution agreement to launch Xebra's ELEMENTS� CBD product line in the United States. This strategic collaboration will continue independently of the terminated acquisition plan.

"Our focus remains on bringing high‑quality CBD products to U.S. consumers under the ELEMENTS� brand," added Gallardo. "We look forward to building a strong commercial presence in the U.S. market with the support of BSK's operational capabilities."

MCTO
Xebra announces that its audited financial statements, CEO and CFO certifications, and management discussion and analysis (the "Annual Filings") for the year ended February 28, 2025 were not released on or prior to the applicable filing deadline on June 30, 2025. The Company was been late in the preparation of the Annual Filings due to management changes and facing certain liquidity constraints and unforeseen delays in the procurement of necessary financial resources to initiate the audit. As further detailed below, the Company has made arrangements to facilitate the completion of the audit and the Annual Filings and the filing thereof.

As a result of the delay, the Company has voluntarily applied for and was granted a management cease trade order, which prohibits certain current directors, officers and insiders of the Company from trading in securities of the Company for so long as the Annual Filings are not filed. The issuance of such management cease trade order generally does not affect the ability of the general investing public to trade in the securities of the Company. The Company intends to provide updates in accordance with National Policy 12-203 - Management Cease Trade Orders with respect to further developments in respect of this matter promptly following their occurrence.

Loan
Xebra announces that it has entered into a loan agreement with an existing shareholder (the "Lender"), a co-founder of Xebra, pursuant to which the Lender has agreed to provide a loan of up C$110,000 to the Company in such principal amounts to be advanced to the Company by the Lender as agreed from time to time (the "Loan").

The Loan is unsecured, bears interest at 10% per annum and matures one year from the date of issuance of the Loan. The Loan will help fund the Company's working capital and general corporate purposes, including but not limited to the audit of the Annual Filings.

About Xebra Brands Ltd.
Xebra Brands is a Canadian cannabis company with international reach, focused on the development and commercialization of cannabis‑derived wellness products. Xebra is the first company to receive full authorization to import, cultivate, manufacture, and sell cannabis (�1% THC) in Mexico, and is actively expanding its ELEMENTS� product line through strategic partnerships in North America.

On behalf of the Board,

"Rodrigo Gallardo"
Interim CEO

For More Information, Contact:
+52�556�387�2293
[email protected]

Cautionary Note Regarding Forward-Looking Statements:

This news release contains certain "forward-looking information" and "forward-looking statements", as such terms are defined under applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements can be identified by the use of words and phrases such as "plans", "expects" ,"is expected", "budget", "scheduled," "estimates", "forecasts", "intends", "anticipates" or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements herein include, but are not limited to, statements with respect to the MCTO, compliance with National Policy 12-203 - Management Cease Trade Orders and the completion of the Annual Filings, including the timing and cost thereof.

These forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other factors, many of which are beyond Xebra's ability to predict or control and could cause actual results to differ materially from those contained in the forward-looking statements. Specific reference is made to Xebra's most recent annual management discussion and analysis on file with certain Canadian provincial securities regulatory authorities for a discussion of some of the factors underlying forward-looking statements, which include, without limitation, Such factors include, but are not limited to, the inability to obtain sufficient financing, the inability of current cash on hand to adequately satisfy current accounts payable, the inability of Xebra to retain the authorizations granted by COFEPRIS, the inability to successfully complete financings on terms acceptable to Xebra or at all, the inability to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete potential acquisitions, dispositions or joint ventures for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approvals for license applications on terms satisfactory to Xebra. In addition, there is no assurance Xebra will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; have products that will be unique. The foregoing list is not exhaustive and Xebra undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect Xebra's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, Xebra. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.

This press release includes market, industry and economic data which was obtained from publicly available sources and other sources believed by Xebra to be true. Although Xebra believes the information to be reliable, it has not independently verified any of the data from third party sources referred to in this press release, or analyzed or verified the underlying reports relied upon or referred to by such sources, or ascertained the underlying economic and other assumptions relied upon by such sources. Xebra believes that its market, industry and economic data is accurate and that its estimates and assumptions are reasonable, but there can be no assurance as to the accuracy or completeness thereof.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Xebra Brands Ltd



View the original on ACCESS Newswire

FAQ

Why did Xebra Brands (XBRAF) terminate the acquisition of BSK Holdings in 2025?

Xebra terminated the acquisition after determining it wasn't in the company's best interest following a thorough due diligence review, though they will maintain their partnership for distributing ELEMENTS� CBD products.

What are the terms of Xebra Brands' new loan agreement in July 2025?

The loan agreement is for up to C$110,000, unsecured, bears a 10% annual interest rate, and matures in one year. The funds will be used for working capital and completing the delayed annual audit.

What caused Xebra Brands' Management Cease Trade Order in 2025?

The MCTO was issued due to Xebra's failure to file annual financial statements by June 30, 2025, caused by management changes, liquidity constraints, and delays in securing resources for the audit.

Will Xebra Brands still launch ELEMENTS� CBD products in the US market?

Yes, despite terminating the BSK Holdings acquisition, Xebra will continue its partnership with BSK to manufacture and distribute the ELEMENTS� CBD product line in the United States.

How does the Management Cease Trade Order affect Xebra Brands' stock trading?

The MCTO only prohibits certain directors, officers, and insiders from trading Xebra's securities until annual filings are completed. The general public can continue trading the stock normally.
Xebra Brands

OTC:XBRAF

XBRAF Rankings

XBRAF Latest News

XBRAF Stock Data

2.63M
61.10M
24.16%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Vancouver